Ñî¹óåú´«Ã½Ò•îl

With their forces—and cash—combined, venture capital outfit Eclipse and Mayo Clinic have teamed up to provide seed funding for new CDMO Nucleus RadioPharma. The company recently debuted a mission to boost radiopharmaceutical access by cranking out new technologies to modernize development, production and supply of the promising cancer meds. (Kansteiner, 10/25)

New data presented last week at the IDWeek conference suggests diagnostic stewardship can play a critical role in reducing unnecessary antibiotic use in patients who are treated for a urinary tract infection when they don't actually have one. (Dall, 10/24)

After European regulators jumped on a global-first approval for Johnson & Johnson’s BCMA-targeted bispecific drug Tecvayli, the U.S. FDA has doled out its own blessing for the novel therapy. (Liu, 10/25)

Amplifica Holdings Group, a San Diego biotech startup working to help balding people regrow their hair, has corralled $11.8 million in a first round of venture capital financing. (Freeman, 10/24)